The role of third-generation beta-blocking agents in chronic heart failure
- 1 December 1998
- journal article
- review article
- Published by Wiley in Clinical Cardiology
- Vol. 21 (S1), I3-I13
- https://doi.org/10.1002/clc.4960211303
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Mechanism of Action of Beta-Blocking Agents in Heart FailureThe American Journal of Cardiology, 1997
- Medical Therapy Can Improve the Biological Properties of the Chronically Failing HeartCirculation, 1996
- Cardiac adrenergic receptor effects of carvedilolEuropean Heart Journal, 1996
- Partial Agonist Activity of CeliprololJournal of Cardiovascular Pharmacology, 1993
- Effect of Oral Milrinone on Mortality in Severe Chronic Heart FailureNew England Journal of Medicine, 1991
- Multicenter trial of oral enoximone in patients with moderate to moderately severe congestive heart failure. Lack of benefit compared with placebo. Enoximone Multicenter Trial Group.Circulation, 1990
- Mechanism of Action of Bucindolol in Human Ventricular MyocardiumJournal of Cardiovascular Pharmacology, 1990
- Pharmacological and Hemodynamic Profile of Nebivolol,* a Chemically Novel, Potent, and Selective β1-Adrenergic AntagonistJournal of Cardiovascular Pharmacology, 1988
- Actions of Dilevalol on AdrenoceptorsJournal of Cardiovascular Pharmacology, 1988
- Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart FailureNew England Journal of Medicine, 1986